In this learning pathway, neuroradiologist Frank Gaillard guides you through the imaging of various epileptogenic brain tumors to increase your practical knowledge and interpretation skills. The pathway primarily focuses on MRI imaging with an emphasis on adults (see course trailer).
Features
- 80 minutes of video content
- 7 scrollable cases with video commentary
- 6 scrollable practice cases with sample reports, questions and discussion
- multiple-choice review questions
- official course certificate
- English subtitles for all videos
6 AMA PRA Category 1 Credits ™
Radiopaedia designates this enduring material CME activity for a maximum of 6 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Intended audience
This learning pathway is primarily targeted at radiologists and radiology trainees. Neuroradiologists will likely find value in completing the pathway to cement a deeper understanding of some uncommon tumors, changes in the 5th edition (2021) WHO classification in regards to some of these tumors and pathophysiology of epilepsy in the setting of tumors. There are also numerous tangents that are relevant more broadly to the practice of neuroradiology.
The content may also be of interest to neurologists, neurosurgeons and other physicians involved in the management of brain tumors (e.g. oncologists, radiation oncologists and neuropathologists).
REGISTRATION OPTIONS
12 Months Access
$40.00 USD
Online access to the complete learning pathway for 12 months
All-Access Pass
Individuals and groups can purchase all-access passes to Radiopaedia.org online courses
Learn more
Free Access
If you are from a low or middle-income region you may be eligible for free access to all Radiopaedia.org courses
Learn more
Course Trailer
Pathway Overview
Author disclosures
This activity was planned and authored by Frank Gaillard who has no relevant financial relationships with ineligible companies to disclose.
The planning of this learning pathway was approved and overseen by the Radiopaedia Educational Board, who themselves had no relevant financial relationships with ineligible companies to disclose.
You can view Frank Gaillard's current disclosures and read more about disclosures and ineligible companies here.
Prior to publication, this activity was:
- peer-reviewed by an expert without relevant financial relationships who has attested that clinical recommendations are evidence-based, free of commercial bias, and support safe, effective patient care
- reviewed by a test audience without relevant financial relationships
Read more about Radiopaedia's peer review policy
Publication and review dates
- Initial publication date: 12 August 2024
- Expiry date: 11 August 2027
All material that is accredited for AMA PRA Category 1 Credit(s)™ is periodically reviewed at least once every three years, or more frequently if indicated by new scientific developments, in line with ACCME and AMA guidelines to ensure it remains valid.
Read more about Radiopaedia's review of enduring material policy
Need help? Try our FAQ page